Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)
China · Delayed Price · Currency is CNY 9.19
+0.11 (1.21%)
Feb 3, 2026, 3:00 PM CST
SHA:600789 Revenue
Shandong Lukang Pharmaceutical had revenue of 1.47B CNY in the quarter ending September 30, 2025, with 5.97% growth. This brings the company's revenue in the last twelve months to 6.19B, up 1.79% year-over-year. In the year 2024, Shandong Lukang Pharmaceutical had annual revenue of 6.23B with 1.41% growth.
Revenue (ttm)
6.19B
Revenue Growth
+1.79%
P/S Ratio
1.53
Revenue / Employee
969.08K
Employees
6,388
Market Cap
9.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.23B | 86.37M | 1.41% |
| Dec 31, 2023 | 6.15B | 525.28M | 9.34% |
| Dec 31, 2022 | 5.62B | 697.66M | 14.17% |
| Dec 31, 2021 | 4.92B | 718.67M | 17.09% |
| Dec 31, 2020 | 4.21B | 472.39M | 12.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition